IDev Technologies, Inc.

40 articles about IDev Technologies, Inc.

• Abbott Laboratories Completes Acquisition of IDev Technologies, Inc.

  8/21/2013

• IDev Technologies, Inc. Announces Results From Revascularization With Supera on Real World Patients (RESTORE) Study, Demonstrating Positive Clinical Outcomes in Significantly Diseased Patients With Long Lesions

  1/31/2013

• IDev Technologies, Inc. Release: Clinical Results for the Supera&#-174 Peripheral Stent System Highlighted at Leading Global Peripheral Intervention Course

  1/25/2013

• IDev Technologies, Inc. Presents Consistent Evidence Validating the Mimetic Design of SUPERA&#0174 Stent

  10/23/2012

• IDev Technologies, Inc.'s Pivotal SUPERB Trial Demonstrates SUPERA&#0174 Stent Significantly Exceeds VIVA Criteria for One-Year Patency in Femoropopliteal Artery Disease

  10/11/2012

• IDev Technologies, Inc. Announces Positive Two-Year Clinical Outcomes From Long Term Registry of the SUPERA&#0174 Stent in Femoropopliteal Artery Disease

  10/11/2012

• IDev Technologies, Inc. Release: SUPERA&#0174 Stent Approved for Private Reimbursement in Australia

  9/27/2012

• IDev Technologies, Inc. Introduces SurePath(TM) Guidewires

  6/11/2012

• IDev Technologies, Inc. Strengthens Commercial Leadership

  6/7/2012

• IDev Technologies, Inc. Release: Journal of Endovascular Therapy Publishes Two-Year Data On SUPERA(R) Stent Used in the Superficial Femoral Artery

  12/15/2011

• IDev Technologies, Inc. Receives FDA Clearance for Its SUPERA VERITAS(R) 6 French Stent Delivery System

  11/10/2011

• IDev Technologies, Inc. Launches Lower Profile SUPERA VERITAS® Stent Delivery System

  7/12/2011

• IDev Technologies, Inc. Announces Completion of SUPERB Clinical Trial Enrollment

  6/2/2011

• Long Lesion Study Demonstrates IDev Technologies, Inc.'s SUPERA(R) Stent Efficacy in SFA and Popliteal Arteries

  5/17/2011

• IDev Technologies, Inc.'s SUPERA VERITAS(R) Receives Regulatory Approval in Australia

  4/28/2011

• IDev Technologies, Inc. Announces Full Canadian Regulatory Approval for SUPERA VERITAS(R)

  4/14/2011

• IDev Technologies, Inc. Release: One-Year European Registry Data Released for Popliteal Stenting With SUPERA(R)

  2/8/2011

• Long-Term European Data Released for SUPERA(R) Stent from IDev Technologies, Inc.

  1/26/2011

• IDev Technologies, Inc. Announces First U.S. Procedure With SUPERA VERITAS(TM) Transhepatic Biliary System

  11/30/2010

• IDev Technologies, Inc. Announces FDA 510(k) Clearance for SUPERA VERITAS(TM)

  11/4/2010